RUO content should keep those phrases separate from procurement copy and focus on compound identity, COA review, analytical testing, lot traceability, and labeling
The new pill people are referring to is the newer oral GLP-1 option associated with Wegovy, not Ozempic
N., Wharton, S., Connery, L., Alves, B., Stefanski, A., et al
doi: 10.1016/j.phrs.2022.106490 26 KimSJeonJSChoiYJBaekGHKimSKKangKW
VivioMD GLP-1 is a telehealth weight-care program that connects patients with an independent licensed medical group and state-licensed pharmacies for GLP-1 and GLP-1+GIP medication options, both compounded and brand-name, following an online health assessment and clinician review